News
The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute ...
President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...
11d
Straight Arrow News on MSNTrump's ‘Big Beautiful Bill' revives incentives for orphan drugsPresident Trump's "Big Beautiful' Bill" includes a provision incentivizing the study of "orphan drugs" to treat rare diseases.
The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.
Of the 43 blockbuster brand name drugs that raked in over $1 billion in annual profits, 18 fell under the orphan drug category. Even smaller biopharmaceutical enterprises are getting in on the action.
The compound annual growth rate of the orphan drug market between 2001 and 2010 was 25.8 percent, compared with 20.1 percent for a matched control group of non-orphan drugs.
Multipronged approach to overcome the challenge of anti-drug antibodies to serve as the foundation of new subsidiary, ...
Orphan drugs are not driving health care spending so let’s invest in them by Peter L. Saltonstall, opinion contributor - 11/01/17 12:40 PM ET ...
Larger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success. Investors and drug developers who still consider orphan drugs as niche ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results